{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:03:01Z","timestamp":1791385381108,"version":"4.3.3"},"reference-count":4,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:p>This case report highlights a temporal relationship between the use of a glucagon-like peptide-1 receptor (GLP-1) agonist and the occurrence of central retinal artery occlusion.<\/jats:p>","DOI":"10.1001\/jamaneurol.2024.5149","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T11:01:35Z","timestamp":1739185295000},"page":"416","source":"Crossref","is-referenced-by-count":6,"title":["Central Retinal Artery Occlusion With Cilioretinal Artery Sparing After Semaglutide Injection"],"prefix":"10.1001","volume":"82","author":[{"given":"Julie M.","family":"Shabto","sequence":"first","affiliation":[{"name":"Edward S. Harkness Eye Institute, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Kyun","family":"Oh","sequence":"additional","affiliation":[{"name":"Edward S. Harkness Eye Institute, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Sharma","sequence":"additional","affiliation":[{"name":"Edward S. Harkness Eye Institute, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"nim240023r1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ajo.2024.04.010","article-title":"Impact of GLP-1 agonists and SGLT-2 inhibitors on diabetic retinopathy progression: an aggregated electronic health record data study.","volume":"265","author":"Wai","year":"2024","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"nim240023r2","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1001\/jamaophthalmol.2024.2296","article-title":"Risk of nonarteritic anterior ischemic optic neuropathy in patients prescribed semaglutide.","volume":"142","author":"Hathaway","year":"2024","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"nim240023r3","doi-asserted-by":"publisher","first-page":"H1159","DOI":"10.1152\/ajpheart.00574.2023","article-title":"GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage.","volume":"326","author":"Park","year":"2024","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"nim240023r4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1507\/endocrj.EJ21-0129","article-title":"Comprehensive analysis of the safety of semaglutide in type 2 diabetes: a meta-analysis of the SUSTAIN and PIONEER trials.","volume":"68","author":"Yin","year":"2021","journal-title":"Endocr J"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2830014\/jamaneurology_shabto_2025_im_240023_1743609766.49022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T11:01:05Z","timestamp":1744628465000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2830014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":4,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2024.5149","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,1]]}}}